| Course | HLTH 5063 Biology and Disease Risk in Human Health |
|---|---|
| Module | Module 5 |
| Paper type | Biology-based policy recommendation |
| Length | 1,180 words, about 4 pages plus title and reference pages |
| Format | APA 7 student paper |
| School | American College of Education |
| Program | Master of Public Health |
| Updated | September 2026 |
Free sample paper for HLTH 5063 Module 5
Test Once, Protect or Treat for Life: A County Policy Recommendation on Adult Hepatitis B Screening, Vaccination and Care, Grounded in the Biology of a Silent Virus
Student Name
American College of Education
HLTH5063: Biology and Disease Risk in Human Health
Module 5 Assignment
Instructor Name
November 2, 2026
The Problem the Policy Addresses
The earlier modules traced hepatitis B from its biology through liver cancer, host susceptibility and national policy. They converge on a single gap. In the composite county, most residents living with chronic hepatitis B were infected as children, many in their countries of birth, feel well and do not know they are infected. Vaccination cannot help them, and a policy that waits for clinicians to test only people they judge to be at risk will keep missing them. National estimates show how large the gap is: awareness of infection among people living with chronic hepatitis B was about 32% in 2013 to 2016, against a national goal of 90% by 2030 (Conners et al., 2023).
This paper recommends that the county board of health adopt a Hepatitis B Test, Protect and Treat Policy with five provisions, each grounded in a biological feature of the virus described earlier in the course.
Provision One: Screen Every Adult Once With Three Tests
Because chronic infection is silent and risk-based testing misses many infected people, the county should adopt CDC's 2023 recommendation to screen all adults aged 18 and older at least once in their lifetime using three laboratory tests: hepatitis B surface antigen, antibody to surface antigen and total antibody to core antigen (Conners et al., 2023). The three-test panel does in one blood draw what used to require several visits. It identifies people with current infection, people who are immune from past infection or vaccination, and people who are susceptible and need vaccination. The recommendation also advises that anyone who asks for testing receive it without having to disclose a risk, because many people are reluctant to report stigmatized risks. The county's own clinics should adopt the panel for every adult patient without a prior result, and the department should ask partner health centers and hospital outpatient practices to do the same.
Provision Two: Vaccinate Everyone Found Susceptible
Screening is also a vaccination opportunity. Adults whose panel shows no immunity should be offered vaccination at the same visit where possible, consistent with the national recommendation for universal vaccination of adults aged 19 to 59 and vaccination of older adults with risk factors or who request it (Weng et al., 2022). Because response to vaccination is lower among older adults and people with diabetes, the county should stock a two-dose adjuvanted vaccine, which in a randomized trial protected 90.0% of participants with type 2 diabetes compared with 65.1% for a three-dose vaccine (Jackson et al., 2018), and should use reminder calls to complete the series.
Provision Three: Link Every Infected Person to Lifelong Care
The infection lodges in the liver for life and its danger climbs with viral activity over decades, so finding infection is only the beginning. Every resident with a positive surface antigen result should be linked within 30 days to a clinician who can measure viral load and liver inflammation, decide on antiviral treatment and arrange liver cancer surveillance where indicated. The biological basis is strong: in a large Taiwanese cohort, adults with the highest viral loads developed liver cancer at roughly ten times the rate of those with the lowest (Chen et al., 2006), which means that monitoring and treating people with active replication can prevent cancers that would otherwise appear years later. The department should employ a patient navigator who speaks Vietnamese and another who speaks French to help residents through referral, insurance enrollment and the first visits. Telling someone they carry hepatitis B without connecting them to care is a diagnosis without a benefit.
Provision Four: Test and Protect Households
Since shared razors, toothbrushes, sexual contact and birth all carry the virus between family members, the household members and sexual partners of every person found to have chronic infection should be offered testing and, if susceptible, vaccination. The navigator will offer this at the first follow-up, with free testing at the department's clinic. This provision catches infections that screening in clinics would miss and protects children and partners who may not yet be infected.
Provision Five: Work Through Communities
Because infection is concentrated among residents who immigrated from Asia, Africa and other high-prevalence areas, and because stigma and fear discourage testing, the county should partner with Vietnamese, Filipino and West African community organizations, faith communities and ethnic media to host screening events, explain in plain language how the virus is and is not spread, and share stories of people living well with treatment. Materials should be written in the relevant languages and reviewed by community members. The department should report screening, vaccination and linkage results by community every year to the partners, so that they can see the policy working.
Anticipated Objections and Responses
A recommendation of this kind will meet objections, and the county should be ready to answer them. Some clinicians will say that universal adult screening wastes tests on people at low risk. The answer is that risk-based screening has been tried for decades and has left a large share of infected adults unaware of their status, because many people either do not know or do not disclose the exposures that put them at risk. A single lifetime test removes that guesswork, and the cost of one panel is small compared with the cost of treating liver failure or cancer found late. Others will worry that people who test positive will face stigma at work or in their communities. The recommendation addresses this by keeping results within the clinical record, training staff to explain that hepatitis B is common and treatable, and working with community organizations whose members are most affected so that the message comes from trusted voices. Budget officers may ask whether linkage to care is affordable for uninsured residents. The county can reduce that cost by using federally qualified health centers, patient assistance programs for antiviral drugs and existing surveillance staff for follow-up calls. Finally, some will ask why the county should act before the state does. The biology does not wait for state policy, and every year of delay allows more infected adults to progress silently toward cirrhosis and liver cancer.
Cost, Measures and Review
The policy's costs are mainly laboratory tests, vaccine, two part-time navigators and outreach events. Economic analysis supporting the national recommendation found that one-time universal screening of adults aged 18 to 69 was cost-saving compared with current practice, assuming antiviral drug costs remained below about $894 a year (Conners et al., 2023), which suggests the county can expect good value, particularly in communities where prevalence is higher than the national average. Progress will be tracked through the proportion of adults in county clinics with a documented panel, the share of susceptible adults who complete vaccination, the share of newly identified infections linked to care within 30 days and the number of household contacts tested. The policy should be reviewed after two years, and its linkage results should be reported by language group so that gaps are visible and addressed.
References
Chen, C.-J., Yang, H.-I., Su, J., Jen, C.-L., You, S.-L., Lu, S.-N., Huang, G.-T., Iloeje, U. H., & REVEAL-HBV Study Group. (2006). Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA, 295(1), 65-73. https://doi.org/10.1001/jama.295.1.65
Conners, E. E., Panagiotakopoulos, L., Hofmeister, M. G., Spradling, P. R., Hagan, L. M., Harris, A. M., Rogers-Brown, J. S., Wester, C., & Nelson, N. P. (2023). Screening and testing for hepatitis B virus infection: CDC recommendations, United States, 2023. MMWR Recommendations and Reports, 72(1), 1-25. https://doi.org/10.15585/mmwr.rr7201a1
Jackson, S., Lentino, J., Kopp, J., Murray, L., Ellison, W., Rhee, M., Shockey, G., Akella, L., Erby, K., Heyward, W. L., Janssen, R. S., & HBV-23 Study Group. (2018). Immunogenicity of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant compared with a licensed hepatitis B vaccine in adults. Vaccine, 36(5), 668-674. https://doi.org/10.1016/j.vaccine.2017.12.038
Weng, M. K., Doshani, M., Khan, M. A., Frey, S., Ault, K., Moore, K. L., Hall, E. W., Morgan, R. L., Campos-Outcalt, D., Wester, C., & Nelson, N. P. (2022). Universal hepatitis B vaccination in adults aged 19-59 years: Updated recommendations of the Advisory Committee on Immunization Practices, United States, 2022. Morbidity and Mortality Weekly Report, 71(13), 477-483. https://doi.org/10.15585/mmwr.mm7113a1
What the HLTH 5063 Module 5 instructions ask for
HLTH 5063 Module 5 usually asks you to recommend a policy for a current health threat and to justify it with the biology of the disease. Prompts typically ask for the problem, the specific provisions, the scientific rationale for each, the populations affected, costs or feasibility, and how success would be measured. Many versions expect the recommendation to build on the disease you have studied throughout the course. Graders reward provisions that are specific enough to implement and a rationale that ties each one to a biological feature, supported by current recommendations and research. Write for a board or agency audience, keep jargon to a minimum, and look at Canvas for whether a formal policy brief format is required.
How this HLTH 5063 Module 5 example is built
The worked recommendation defines the gap left by earlier policies and quantifies it from national data. Each of five provisions then gets its own section with its biological rationale and its source: universal screening with a three-test panel because infection is silent; vaccination of the susceptible, tailored to host factors that lower response; linkage to care because the virus persists and cancer risk rises with viral activity; household testing because of how the virus spreads; and community partnership because infection is concentrated and stigmatized. The paper closes with costs supported by economic evidence, measures and a review schedule with equity reporting.
Where the points sit in the HLTH 5063 Module 5 rubric
Policy recommendation rubrics in this course generally reward a well-defined problem, specific provisions, a clear biological rationale for each, use of current authoritative recommendations and attention to feasibility and equity. Graders check that each provision is tied to a scientific fact rather than justified in general terms. Current recommendations should be cited from their primary source. Feasibility earns points when costs and staffing are addressed, ideally with economic evidence. Measures of success and a review process are commonly required. Attention to the communities most affected, including language and stigma, strengthens the score. A clean APA 7 reference list, with official recommendations cited by agency and year, completes the rubric.
HLTH 5063 Module 5 help from the desk
Recommendation papers lose points when provisions are too vague to implement, such as increase awareness of hepatitis B. Another frequent problem is citing old recommendations when newer ones exist, or presenting a changed policy as current. Students also forget what happens after a diagnosis, recommending testing without linkage to care. Write provisions with specific actions and timelines. Tie each to a biological reason. Cite the current recommendation directly. Say how you will measure success. Tuberculosis, HPV or lead poisoning policies can be built the same way; describe the threat and attach your instructions, and we will draft a Module 5 recommendation whose provisions each rest on the biology you studied earlier in the course.
Write yours, or have the desk draft it
This paper is an original model document written by our desk, not a submitted student paper and not an official American College of Education document. Read it for the moves, then write your own to the instructions in your classroom. If you want one built to your exact prompt and rubric, the first custom sample is free and arrives in 24 to 48 hours.
More HLTH 5063 and Master of Public Health sample papers
- HLTH 5063 Module 1: Disease Biology and Transmission
- HLTH 5063 Module 2: Disease Risk Factor Analysis
- HLTH 5063 Module 3: Host Susceptibility Analysis
- HLTH 5063 Module 4: Biology and Policy Analysis
- HLTH 5053 Module 4: Risk Communication Plan
- HLTH 5023 Module 3: Public Health Ethics Analysis
- HLTH 5033 Module 1: Financial Statement Analysis
- HLTH 5053 Module 5: Campaign Plan and Evaluation
HLTH 5063 Module 5 questions, answered
What does HLTH5063 Module 5 usually ask for?
HLTH5063 frequently ends with a policy recommendation for a current health threat that is explicitly grounded in the disease's biology, with provisions, justification, costs and measures. The disease comes from your own section.
What is the triple panel for hepatitis B screening?
Three blood tests, surface antigen, antibody to surface antigen and total antibody to core antigen, that together show whether a person is infected, immune or susceptible.
Who should be screened for hepatitis B?
CDC's 2023 recommendations call for screening all adults aged 18 and older at least once with the three-test panel, plus risk-based testing and testing for anyone who asks.
Where can I find a free HLTH 5063 Module 5 sample paper?
This page posts the complete Module 5 policy recommendation for adult hepatitis B screening, vaccination and care in a county, with five provisions each tied to the virus's biology, plus costs and measures.
Why link people with chronic hepatitis B to ongoing care?
Because the virus persists and liver cancer risk rises with viral activity, monitoring and treatment over time can prevent serious complications.